BRAIN Biotech AG

Equities

BNN

DE0005203947

Market Closed - Xetra Other stock markets 11:36:22 2025-01-17 am EST			5-day change	1st Jan Change
3.310 ^EUR	+1.85%		-4.89%	-6.76%

Jan. 14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
Dec. 12	BRAIN Biotech AG - Analyst/Investor Day

BRAIN Biotech AG, Q2 2023 Earnings Call, May 25, 2023

May 25, 2023 at 05:00 am EDT

Presenter Speech
Michael Schneiders (Executives)

Hello. My name is Michael Schneiders. I'm the CFO of BRAIN Biotech AG. We are located in Germany, just between Frankfurt and Sternberg. And I'm very

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about BRAIN Biotech AG

BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	Jan. 14	CI
BRAIN Biotech AG - Analyst/Investor Day	Dec. 12
BRAIN Biotech AG Announces Resignation of Wiltrud Treffenfeldt as Member of the Supervisory Board	24-10-03	CI
Brain Biotech Signs EUR129 Million Royalty Deal for Hereditary Angioedema Treatment Compound	24-09-23	MT
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	24-08-29	CI
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	24-05-28	CI
Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	24-04-16	MT
BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	24-03-05	CI
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	24-02-28	CI
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2023	24-01-17	CI
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-29	CI
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-25	CI
BRAIN Biotech AG, Q2 2023 Earnings Call, May 25, 2023	23-05-25
BRAIN Biotech to Look Acquisitions	23-05-24	CI
BRAIN Biotech AG acquired remaining 17.8% stake in Biocatalysts Limited for ?9.6 million.	23-05-23	CI
SolasCure Limited announced that it has received £10.9 million in funding from Seneca Partners Limited, BRAIN Biotech AG, Eva Pharma Consultants Ltd, Wealth Club Limited and another investor	23-03-26	CI
BRAIN Biotech AG announced that it expects to receive ?5 million in funding from MP Beteiligungs-Gmbh	23-03-07	CI
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-27	CI
BRAIN Biotech Ends Contract with Roquette Frères on Natural Sweetener Joint Development	23-02-10	MT
BRAIN Biotech Unit to Focus on Developing New Therapies Via Genome-editing Technology	23-01-10	MT
BRAIN Biotech AG Announces Executive Changes	23-01-08	CI
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2022	22-11-28	CI
La Cultura Verde Ltd. acquired LA Schmitt from BRAIN Biotech AG.	22-09-25	CI
BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-28	CI
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-06-03	CI